Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynne Lennard

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
British Journal of Clinical Pharmacology|August 22, 2013
Implementation of TPMT testingLynne Lennard
Journal of Clinical Pathology|September 27, 2015
An assessment of methods used in the investigation of iron status: findings in a population of young British South Asian childrenRoderick F Hinchliffe, Ajay J Vora, Lynne Lennard
British Journal of Haematology|May 6, 2015
Thiopurine methyltransferase and treatment outcome in the UK acute lymphoblastic leukaemia trial ALL2003Lynne Lennard, Cher S Cartwright, Rachel Wade, et al.
British Journal of Haematology|December 3, 2014
Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogeneticsLynne Lennard, Cher S Cartwright, Rachel Wade, et al.
British Journal of Haematology|September 27, 2003
Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemiaSara Stoneham, Lynne Lennard, Pietro Coen, et al.
British Journal of Clinical Pharmacology|December 21, 2012
Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemiaLynne Lennard, Cher Suzanne Cartwright, Rachel Wade, et al.
Clinical Pharmacology and Therapeutics|October 4, 2006
The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemiaLynne Lennard, Sue Richards, Cher S Cartwright, et al.
Archives of Disease in Childhood|May 24, 2013
Utility of red cell distribution width in screening for iron deficiencyRoderick F Hinchliffe, Graham J Bellamy, Adam Finn, et al.
Hepatology (Baltimore, Md.)|April 11, 2012
Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitisHarpreet K Dhaliwal, Rory Anderson, Elizabeth L Thornhill, et al.
Lancet (London, England)|October 19, 2006
Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trialAjay Vora, Chris D Mitchell, Lynne Lennard, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
British Journal of Clinical Pharmacology|August 22, 2013
Implementation of TPMT testingLynne Lennard
Journal of Clinical Pathology|September 27, 2015
An assessment of methods used in the investigation of iron status: findings in a population of young British South Asian childrenRoderick F Hinchliffe, Ajay J Vora, Lynne Lennard
British Journal of Haematology|May 6, 2015
Thiopurine methyltransferase and treatment outcome in the UK acute lymphoblastic leukaemia trial ALL2003Lynne Lennard, Cher S Cartwright, Rachel Wade, et al.
British Journal of Haematology|December 3, 2014
Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogeneticsLynne Lennard, Cher S Cartwright, Rachel Wade, et al.
British Journal of Haematology|September 27, 2003
Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemiaSara Stoneham, Lynne Lennard, Pietro Coen, et al.
British Journal of Clinical Pharmacology|December 21, 2012
Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemiaLynne Lennard, Cher Suzanne Cartwright, Rachel Wade, et al.
Clinical Pharmacology and Therapeutics|October 4, 2006
The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemiaLynne Lennard, Sue Richards, Cher S Cartwright, et al.
Archives of Disease in Childhood|May 24, 2013
Utility of red cell distribution width in screening for iron deficiencyRoderick F Hinchliffe, Graham J Bellamy, Adam Finn, et al.
Hepatology (Baltimore, Md.)|April 11, 2012
Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitisHarpreet K Dhaliwal, Rory Anderson, Elizabeth L Thornhill, et al.
Lancet (London, England)|October 19, 2006
Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trialAjay Vora, Chris D Mitchell, Lynne Lennard, et al.
Pageof 2